Meta-Analysis of the Role of Cangrelor for Patients Undergoing Percutaneous Coronary Intervention

Inhibition of the P2Y12 receptor by an oral P2Y12 inhibitor with loading doses along with Cyclooxygenase-1 inhibition by aspirin is considered a first-line treatment strategy in patients with the acute coronary syndrome and patients undergoing percutaneous coronary intervention (PCI). Limitations as...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American journal of cardiology 2019-04, Vol.123 (7), p.1069-1075
Hauptverfasser:	Majmundar, Monil, Kansara, Tikal, Jain, Akash, Shah, Palak, Mithawala, Priyam, Desai, Rupak, Shah, Priyank, Doshi, Rajkumar
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Coronary Syndrome - mortality Acute Coronary Syndrome - therapy Acute coronary syndromes Adenosine Monophosphate - analogs & derivatives Adenosine Monophosphate - therapeutic use Adenosine triphosphate Angina pectoris Angioplasty Aspirin ATP Bleeding Blood platelets Clinical trials Clopidogrel Complications Cyclooxygenase-1 Drug delivery Drug dosages Global Health Heart attacks Humans Implants Inhibition Inhibitors Intervention Intravenous administration Ischemia Meta-analysis Myocardial infarction Patients Percutaneous Coronary Intervention - methods Platelets Preoperative Care - methods Purinergic P2Y Receptor Antagonists - therapeutic use Stents Surgery Surgical implants Survival Rate - trends Thromboembolism Thrombosis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!